Do nanoparticles induce neurodegenerative diseases? Understanding the origin of reactive oxidative species and protein aggregation and mis-folding phenomena in the presence of nanoparticles
As the use of nanoparticles becomes more prevalent, it is clear that human exposure will inevitably increase. Considering the rapidly ageing European population and the resulting increase in the incidence of neurodegenerative diseases, there is an urgent need to address the risk presented by nanoparticles towards neurodegenerative diseases.
See more:
Short name and number:
NeuroNano (214547)
Name of US Partner:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, UNIVERSITY OF ROCHESTER, WILLIAM MARSH RICE UNIVERSITY,
Contact:
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Participating Countries:
Japan
Area:
Nanosciences, nanotechnologies, materials and new production technologies
Category:
FP7 Project with U.S. partner
